Table 2

Best overall response and overall response rate among molecular subtypes

Pathogenic or likely pathogenic n=56VUS n=45
Best response, n (%)
 Complete response (CR)2 (4%)1 (2%)
 Partial response (PR)28 (50%)5 (11%)
 Stable disease12 (21%)15 (33%)
 Progressive disease13 (23%)19 (42%)
 Not evaluable1 (1.8%)5 (11%)
 Overall response (CR+PR), n (%) (95% CI)30 (54%) (40% to 67%)6 (13%) (5% to 27%)
 OR of CR+PR (95% CI)7.5 (2.9 to 22.3), p=0.0009Reference (1.0)
  • VUS, variants of unknown significance.